Title:
NASAL ADMINISTRATION OF THE LH-RH ANALOG LEUPROLIDE
Document Type and Number:
WIPO Patent Application WO2004098513
Kind Code:
A3
Abstract:
The invention provides a composition for a nasal administration that includes leuprolide and one bioadhesive material that is chitosan. Methods of administration of leuprolide to a mammal suffering from a leuprolide modulated condition, such as endometriosis, prostate cancers, hypogonadism, pre-menstrual syndrome, or uterine leiomyomas.
Inventors:
IQBAL KHURSHID (US)
FISHER ANTHONY (GB)
WATTS PETER (GB)
FISHER ANTHONY (GB)
WATTS PETER (GB)
Application Number:
PCT/US2004/013498
Publication Date:
August 25, 2005
Filing Date:
May 03, 2004
Export Citation:
Assignee:
WEST PHARM SERV DRUG RES LTD (GB)
IQBAL KHURSHID (US)
FISHER ANTHONY (GB)
WATTS PETER (GB)
IQBAL KHURSHID (US)
FISHER ANTHONY (GB)
WATTS PETER (GB)
International Classes:
A01N37/18; A61K9/00; A61K38/00; A61K38/09; A61K47/36; A61K; (IPC1-7): A01N37/18; A61K38/00
Foreign References:
| US6465626B1 | 2002-10-15 |
Other References:
"Nasal Neuprolide Formulation", PHARMALICENSING, 19 May 2000 (2000-05-19), pages 1
"Optinose has recently been featured in the american journal, phermaceutical formulation & quality. Nothing to sneeze at. Often overlooked and long neglected, the nose has become one of the most viable drug delivery phatways for treating everything from the flu to erectile dysfunction.", OPTINOSE DRUG DEVICES., 21 November 2002 (2002-11-21), pages 1 - 3
"Optinose has recently been featured in the american journal, phermaceutical formulation & quality. Nothing to sneeze at. Often overlooked and long neglected, the nose has become one of the most viable drug delivery phatways for treating everything from the flu to erectile dysfunction.", OPTINOSE DRUG DEVICES., 21 November 2002 (2002-11-21), pages 1 - 3
Download PDF: